SCHEDULE: Vanguard Group Reduces Insmed Stake to Zero
Amendment to Schedule 13G
The Vanguard Group reported a 0% beneficial ownership in Insmed Inc. common stock following an internal realignment.
Summary
- The Vanguard Group filed an Amendment No. 11 to Schedule 13G for Insmed Inc.
- The filing indicates that The Vanguard Group now beneficially owns 0% of Insmed Inc.'s common stock.
- This change is due to an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions will report their beneficial ownership separately, in reliance on SEC Release No. 34-39538.
- The Vanguard Group, Inc. itself no longer has, or is deemed to have, beneficial ownership over these securities.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing. The change in beneficial ownership by The Vanguard Group is attributed to an internal realignment rather than a shift in investment sentiment towards Insmed Inc.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that such internal realignments within large asset managers like The Vanguard Group are not uncommon and typically reflect organizational restructuring rather than a change in investment thesis regarding the underlying issuer. The disaggregated reporting aligns with SEC guidance for complex organizational structures.
Stakeholder Impact
- Shareholders of Insmed Inc. may observe a change in reported institutional ownership, but the underlying investment by Vanguard's various funds and divisions may still exist, just reported differently.
- The Vanguard Group's internal realignment primarily impacts its own reporting structure and compliance.
Key Dates
| Date | Description |
|---|---|
| 01/12/2026 | Internal realignment within The Vanguard Group, Inc. leading to disaggregated reporting of beneficial ownership. |
| 03/13/2026 | Date of event requiring the filing of this Schedule 13G/A. |
| 03/27/2026 | Date of filing of the Schedule 13G/A. |
Recommendation
holdThe filing primarily details an administrative change in how The Vanguard Group reports its beneficial ownership, rather than a strategic divestment based on Insmed Inc.'s fundamentals. As such, it does not provide new information warranting a change in investment recommendation for Insmed Inc. based solely on this filing.
Keywords
Insmed Inc, Vanguard Group, Schedule 13G/A, Beneficial Ownership, Institutional Ownership, Common Stock, SEC Filing, Investment Management, Internal Realignment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.